SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System.
Agilent Technologies Inc. and Integrated DNA Technologies (IDT) have partnered to provide a complete solution for qPCR studies. The combination of the Mx3005P qPCR system and Brilliant qPCR reagents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results